Ceredex Value Advisors’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Sell
213,450
-144,850
-40% -$6.76M 0.36% 113
2026
Q1
$12.9M Sell
358,300
-4,600
-1% -$192K 0.41% 112
2025
Q4
$17.1M Sell
362,900
-133,100
-27% -$5.62M 0.51% 93
2025
Q3
$16.1M Buy
496,000
+281,750
+132% +$10M 0.37% 99
2025
Q2
$8.83M Sell
214,250
-65,050
-23% -$2.51M 0.19% 155
2025
Q1
$11.7M Buy
279,300
+34,600
+14% +$1.8M 0.26% 130
2024
Q4
$14.3M Buy
+244,700
New +$14.5M 0.29% 112
2022
Q4
Sell
-147,400
Closed -$7.82M 162
2022
Q3
$7.82M Sell
147,400
-3,044
-2% -$182K 0.13% 133
2022
Q2
$9.44M Sell
150,444
-1,035,918
-87% -$63.5M 0.14% 130
2022
Q1
$76.3M Buy
1,186,362
+87,953
+8% +$6.01M 0.92% 44
2021
Q4
$92.2M Buy
1,098,409
+288,427
+36% +$23.1M 1% 34
2021
Q3
$63.3M Buy
809,982
+589,166
+267% +$49M 0.72% 57
2021
Q2
$16.8M Sell
220,816
-203,100
-48% -$14.2M 0.19% 104
2021
Q1
$27.2M Sell
423,916
-23,400
-5% -$1.41M 0.32% 97
2020
Q4
$24.2M Buy
447,316
+716
+0.2% +$34.3K 0.31% 89
2020
Q3
$17.8M Sell
446,600
-2,500
-0.6% -$104K 0.26% 91
2020
Q2
$18.3M Buy
449,100
+46,700
+12% +$1.84M 0.27% 94
2020
Q1
$14.4M Buy
+402,400
New +$18.7M 0.25% 93

Other funds holding BRKR

Ceredex Value Advisors's BRKR Position: Q2 2026 in Review

Ceredex Value Advisors reduced its Bruker (BRKR) stake by 40% in Q2 2026, selling an estimated $6.76M and leaving 213,450 shares worth $12.8M. The position accounts for 0.36% of the portfolio, ranked #113.

Ceredex Value Advisors first reported a position in BRKR in Q1 2020 and has held it in 18 quarters since. The position peaked at $92.2M in Q4 2021. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Ceredex Value Advisors held 213,450 shares of Bruker worth $12.8M as of Q2 2026.
  • Ceredex Value Advisors sold 144,850 Bruker shares in Q2 2026, an estimated $6.76M.
  • Bruker made up 0.36% of Ceredex Value Advisors's portfolio in Q2 2026, its #113 holding.
  • Ceredex Value Advisors first reported a position in Bruker in Q1 2020 and has held it in 18 quarters since.
  • Ceredex Value Advisors's Bruker position peaked at $92.2M in Q4 2021.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.